KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $214.5 million.

  • West Pharmaceutical Services' Other Accumulated Expenses rose 1397.45% to $214.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $214.5 million, marking a year-over-year increase of 1397.45%. This contributed to the annual value of $214.5 million for FY2025, which is 1397.45% up from last year.
  • According to the latest figures from Q4 2025, West Pharmaceutical Services' Other Accumulated Expenses is $214.5 million, which was up 1397.45% from $213.1 million recorded in Q3 2025.
  • Over the past 5 years, West Pharmaceutical Services' Other Accumulated Expenses peaked at $222.8 million during Q2 2025, and registered a low of $136.5 million during Q3 2023.
  • Moreover, its 5-year median value for Other Accumulated Expenses was $165.7 million (2021), whereas its average is $171.0 million.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first soared by 4854.56% in 2021, then tumbled by 1556.04% in 2023.
  • West Pharmaceutical Services' Other Accumulated Expenses (Quarter) stood at $163.4 million in 2021, then rose by 12.48% to $183.8 million in 2022, then dropped by 15.56% to $155.2 million in 2023, then rose by 21.26% to $188.2 million in 2024, then rose by 13.97% to $214.5 million in 2025.
  • Its Other Accumulated Expenses stands at $214.5 million for Q4 2025, versus $213.1 million for Q3 2025 and $222.8 million for Q2 2025.